Bone Loss in Patients With Anorexia Nervosa
- Conditions
- Patients With Anorexia Nervosa
- Registration Number
- NCT01907464
- Lead Sponsor
- University Hospital, Montpellier
- Brief Summary
Nutritional deprivation of adolescent girls with anorexia nervosa (AN) reduces the bone mass acquisition. A better understanding of this process would improve the medical treatment of bone alteration and its long-term consequences.
160 patients (age \< 38 yr) with AN and 160 age-matched controls (CON) will be enrolled in this study. The areal bone mineral density (aBMD) will be determined using dual-X-ray absorptiometry. Calciotropic hormones, bone turnover markers will be concomitantly evaluated.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- Female
- Target Recruitment
- 320
- Informed Consent
- Health Insurance regimen or benefit from an health insurance regimen
- Aged from 14 to 38 years old
- Women
- No pregnant
Specific inclusion criteria for patient:
Patient suffering from anorexia nervosa defined by criteria of Diagnostic and Statistical Manual of Mental Disorders (DSM-IV)
Specific inclusion criteria for controls:
- Normal menstrual cycles,
- No lifetime history of eating disorders,
- BMI between 18 and 25 kg/m²
- use of treatments may be modify bone mass (bisphosphonates,...)
- Disease or treatment may be induce osteoporosis
- In exclusion period in relation with another study
- Law protected subject
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Dual-X-ray absorptiometry (DEXA) at Day 0 (time of the inclusion visit) The primary outcome is to model the bone mass acquisition in young women with anorexia nervosa.
- Secondary Outcome Measures
Name Time Method Biological parameters identification At day 0 (time of the inclusion visit) One of the secondary outcome is to identify biological factors associated with bone demineralisation.
clinical parameters identification At Day 0 (at time of the the inclusion visit) One of the secondary outcome is to identify the clinical factors associated with bone demineralisation.
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (1)
CHU de Montpellier - Département d'Endocrinologie Diabète
🇫🇷Montpellier, France
CHU de Montpellier - Département d'Endocrinologie Diabète🇫🇷Montpellier, FranceLaurent LM MAIMOUN, PhDContact+33 4 67 33 79 99l-maimoun@chu-montpellier.frPatrick PL LEFEBVRE, MDPrincipal Investigator